Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Identification of a Japanese family with LRRK2 p.R1441G-related Parkinson's disease.

Hatano T, Funayama M, Kubo S, Mata IF, Oji Y, Mori A, Zabetian CP, Waldherr SM, Yoshino H, Oyama G, Shimo Y, Fujimoto K, Oshima H, Kunii Y, Yabe H, Mizuno Y, Hattori N.

Neurobiol Aging. 2014 Nov;35(11):2656.e17-23. doi: 10.1016/j.neurobiolaging.2014.05.025. Epub 2014 Jun 2.

2.

Parkinson's disease: Exit toxins, enter genetics.

Westerlund M, Hoffer B, Olson L.

Prog Neurobiol. 2010 Feb 9;90(2):146-56. doi: 10.1016/j.pneurobio.2009.11.001. Epub 2009 Nov 17. Review.

3.

Leucine-rich repeat kinase 2 mutations and Parkinson's disease: three questions.

Greggio E, Cookson MR.

ASN Neuro. 2009 Apr 14;1(1). pii: e00002. doi: 10.1042/AN20090007. Review.

4.

The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy.

Cho JW, Kim SY, Park SS, Jeon BS.

J Clin Neurol. 2009 Mar;5(1):29-32. doi: 10.3988/jcn.2009.5.1.29. Epub 2009 Mar 31.

5.

LRRK2 mutations and risk variants in Japanese patients with Parkinson's disease.

Zabetian CP, Yamamoto M, Lopez AN, Ujike H, Mata IF, Izumi Y, Kaji R, Maruyama H, Morino H, Oda M, Hutter CM, Edwards KL, Schellenberg GD, Tsuang DW, Yearout D, Larson EB, Kawakami H.

Mov Disord. 2009 May 15;24(7):1034-41. doi: 10.1002/mds.22514.

6.

Lrrk2 R1441G-related Parkinson's disease: evidence of a common founding event in the seventh century in Northern Spain.

Mata IF, Hutter CM, González-Fernández MC, de Pancorbo MM, Lezcano E, Huerta C, Blazquez M, Ribacoba R, Guisasola LM, Salvador C, Gómez-Esteban JC, Zarranz JJ, Infante J, Jankovic J, Deng H, Edwards KL, Alvarez V, Zabetian CP.

Neurogenetics. 2009 Oct;10(4):347-53. doi: 10.1007/s10048-009-0187-z. Epub 2009 Mar 24.

7.

Leucine-rich repeat kinase 2 (LRRK2): a key player in the pathogenesis of Parkinson's disease.

Gandhi PN, Chen SG, Wilson-Delfosse AL.

J Neurosci Res. 2009 May 1;87(6):1283-95. doi: 10.1002/jnr.21949. Review.

8.

LRRK2 gene G2019S mutation and SNPs [haplotypes] in subtypes of Parkinson's disease.

Patra B, Parsian AJ, Racette BA, Zhao JH, Perlmutter JS, Parsian A.

Parkinsonism Relat Disord. 2009 Mar;15(3):175-80. doi: 10.1016/j.parkreldis.2008.05.004. Epub 2008 Aug 26.

9.

LRRK2 G2019S in families with Parkinson disease who originated from Europe and the Middle East: evidence of two distinct founding events beginning two millennia ago.

Zabetian CP, Hutter CM, Yearout D, Lopez AN, Factor SA, Griffith A, Leis BC, Bird TD, Nutt JG, Higgins DS, Roberts JW, Kay DM, Edwards KL, Samii A, Payami H.

Am J Hum Genet. 2006 Oct;79(4):752-8. Epub 2006 Aug 17.

Items per page

Supplemental Content

Write to the Help Desk